skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanisms
CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanisms
Material Type:
Artigo 		Adicionar ao Meu Espaço

CD155 loss enhances tumor suppression via combined host and tumor-intrinsic mechanisms

Li, Xian-Yang ; Das, Indrajit ; Lepletier, Ailin ; Addala, Venkateswar ; Bald, Tobias ; Stannard, Kimberley ; Barkauskas, Deborah ; Liu, Jing ; Aguilera, Amelia Roman ; Takeda, Kazuyoshi ; Braun, Matthias ; Nakamura, Kyohei ; Jacquelin, Sebastien ; Lane, Steven W ; Teng, Michele Wl ; Dougall, William C ; Smyth, Mark J

The Journal of clinical investigation, 2018-06, Vol.128 (6), p.2613-2625 [Periódico revisado por pares]

United States: American Society for Clinical Investigation

Texto completo disponível

Citações Citado por
2
Mechanisms Controlling PD-L1 Expression in Cancer
Mechanisms Controlling PD-L1 Expression in Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Mechanisms Controlling PD-L1 Expression in Cancer

Cha, Jong-Ho ; Chan, Li-Chuan ; Li, Chia-Wei ; Hsu, Jennifer L. ; Hung, Mien-Chie

Molecular cell, 2019-11, Vol.76 (3), p.359-370 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
3
Development of Antibody-Based PROTACs for the Degradation of the Cell-Surface Immune Checkpoint Protein PD-L1
Development of Antibody-Based PROTACs for the Degradation of the Cell-Surface Immune Checkpoint Protein PD-L1
Material Type:
Artigo 		Adicionar ao Meu Espaço

Development of Antibody-Based PROTACs for the Degradation of the Cell-Surface Immune Checkpoint Protein PD-L1

Cotton, Adam D ; Nguyen, Duy P ; Gramespacher, Josef A ; Seiple, Ian B ; Wells, James A

Journal of the American Chemical Society, 2021-01, Vol.143 (2), p.593-598 [Periódico revisado por pares]

United States: American Chemical Society

Texto completo disponível

Citações Citado por
4
Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study
Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study

Chung, Hyun Cheol ; Ros, Willeke ; Delord, Jean-Pierre ; Perets, Ruth ; Italiano, Antoine ; Shapira-Frommer, Ronnie ; Manzuk, Lyudmila ; Piha-Paul, Sarina A ; Xu, Lei ; Zeigenfuss, Susan ; Pruitt, Scott K ; Leary, Alexandra

Journal of clinical oncology, 2019-06, Vol.37 (17), p.1470-1478 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
5
CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity
CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity
Material Type:
Artigo 		Adicionar ao Meu Espaço

CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity

Fu, Wenyan ; Lei, Changhai ; Liu, Shuowu ; Cui, Yingshu ; Wang, Chuqi ; Qian, Kewen ; Li, Tian ; Shen, Yafeng ; Fan, Xiaoyan ; Lin, Fangxing ; Ding, Min ; Pan, Mingzhu ; Ye, Xuting ; Yang, Yongji ; Hu, Shi

Nature communications, 2019-09, Vol.10 (1), p.4355-12, Article 4355 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
6
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
Material Type:
Artigo 		Adicionar ao Meu Espaço

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline

Brahmer, Julie R ; Lacchetti, Christina ; Schneider, Bryan J ; Atkins, Michael B ; Brassil, Kelly J ; Caterino, Jeffrey M ; Chau, Ian ; Ernstoff, Marc S ; Gardner, Jennifer M ; Ginex, Pamela ; Hallmeyer, Sigrun ; Holter Chakrabarty, Jennifer ; Leighl, Natasha B ; Mammen, Jennifer S ; McDermott, David F ; Naing, Aung ; Nastoupil, Loretta J ; Phillips, Tanyanika ; Porter, Laura D ; Puzanov, Igor ; Reichner, Cristina A ; Santomasso, Bianca D ; Seigel, Carole ; Spira, Alexander ; Suarez-Almazor, Maria E ; Wang, Yinghong ; Weber, Jeffrey S ; Wolchok, Jedd D ; Thompson, John A

Journal of clinical oncology, 2018-06, Vol.36 (17), p.1714-1768 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
7
Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma
Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma

Roemer, Margaretha G M ; Redd, Robert A ; Cader, Fathima Zumla ; Pak, Christine J ; Abdelrahman, Sara ; Ouyang, Jing ; Sasse, Stephanie ; Younes, Anas ; Fanale, Michelle ; Santoro, Armando ; Zinzani, Pier Luigi ; Timmerman, John ; Collins, Graham P ; Ramchandren, Radhakrishnan ; Cohen, Jonathon B ; De Boer, Jan Paul ; Kuruvilla, John ; Savage, Kerry J ; Trneny, Marek ; Ansell, Stephen ; Kato, Kazunobu ; Farsaci, Benedetto ; Sumbul, Anne ; Armand, Philippe ; Neuberg, Donna S ; Pinkus, Geraldine S ; Ligon, Azra H ; Rodig, Scott J ; Shipp, Margaret A

Journal of clinical oncology, 2018-04, Vol.36 (10), p.942-950 [Periódico revisado por pares]

United States: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
8
Immune-related adverse events with immune checkpoint blockade: a comprehensive review
Immune-related adverse events with immune checkpoint blockade: a comprehensive review
Material Type:
Artigo 		Adicionar ao Meu Espaço

Immune-related adverse events with immune checkpoint blockade: a comprehensive review

Michot, J.M ; Bigenwald, C ; Champiat, S ; Collins, M ; Carbonnel, F ; Postel-Vinay, S ; Berdelou, A ; Varga, A ; Bahleda, R ; Hollebecque, A ; Massard, C ; Fuerea, A ; Ribrag, V ; Gazzah, A ; Armand, J.P ; Amellal, N ; Angevin, E ; Noel, N ; Boutros, C ; Mateus, C ; Robert, C ; Soria, J.C ; Marabelle, A ; Lambotte, O

European journal of cancer (1990), 2016-02, Vol.54, p.139-148 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity
CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity
Material Type:
Artigo 		Adicionar ao Meu Espaço

CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity

Burr, Marian L ; Sparbier, Christina E ; Chan, Yih-Chih ; Williamson, James C ; Woods, Katherine ; Beavis, Paul A ; Lam, Enid Y N ; Henderson, Melissa A ; Bell, Charles C ; Stolzenburg, Sabine ; Gilan, Omer ; Bloor, Stuart ; Noori, Tahereh ; Morgens, David W ; Bassik, Michael C ; Neeson, Paul J ; Behren, Andreas ; Darcy, Phillip K ; Dawson, Sarah-Jane ; Voskoboinik, Ilia ; Trapani, Joseph A ; Cebon, Jonathan ; Lehner, Paul J ; Dawson, Mark A

Nature (London), 2017-09, Vol.549 (7670), p.101-105 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
10
Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer
Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer

Peng, Jin ; Hamanishi, Junzo ; Matsumura, Noriomi ; Abiko, Kaoru ; Murat, Kumuruz ; Baba, Tsukasa ; Yamaguchi, Ken ; Horikawa, Naoki ; Hosoe, Yuko ; Murphy, Susan K ; Konishi, Ikuo ; Mandai, Masaki

Cancer research (Chicago, Ill.), 2015-12, Vol.75 (23), p.5034-5045 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (4.769)

Refinar Meus Resultados

Assunto 

  1. Science & Technology  (4.715)
  2. Life Sciences & Biomedicine  (4.348)
  3. Humans  (4.203)
  4. Immunology  (2.140)
  5. Female  (1.976)
  6. Animals  (1.952)
  7. Oncology  (1.915)
  8. B7-H1 Antigen - Metabolism  (1.910)
  9. Immunotherapy  (1.843)
  10. B7-H1 Antigen - Immunology  (1.622)
  11. Mice  (1.468)
  12. Male  (1.430)
  13. Pd-L1 Protein  (1.370)
  14. B7-H1 Antigen - Antagonists & Inhibitors  (1.230)
  15. Tumors  (1.185)
  16. Middle Aged  (1.124)
  17. Lymphocytes  (1.097)
  18. Apoptosis  (1.038)
  19. Pd-L1  (1.014)
  20. B7-H1 Antigen - Genetics  (1.014)
  21. Mais opções open sub menu

Idioma 

  1. Inglês  (4.935)
  2. Japonês  (934)
  3. Francês  (16)
  4. Chinês  (5)
  5. Tcheco  (3)
  6. Alemão  (2)
  7. Norueguês  (2)
  8. Espanhol  (2)
  9. Russo  (1)
  10. Italiano  (1)
  11. Português  (1)
  12. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.